Pentavalent 99Tcm-dmsa imaging in patients with bone metastases

Nuclear Medicine Communications

Volumn 18, Issue 10, 1997, Pages 907-914

  Lam, A S K ^a   Kettle, A G ^b   Odoherty, M J ^b   Coakley, A J ^b   Barrington, S F ^b   Blower, P J ^a,b  

^a KENT AND CANTERBURY HOSPITAL   (United Kingdom)

^b UNIVERSITY OF CANTERBURY   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT; SUCCIMER TC 99M; TECHNETIUM COMPLEX; TECHNETIUM TC 99M HYDROXYDIPHOSPHONATE; OXIDRONATE TECHNETIUM TC 99M; PENTAVALENT SUCCIMER TC 99M; RHENIUM 186; RHENIUM 188; UNCLASSIFIED DRUG;

ARTICLE; BONE TUMOR; BREAST TUMOR; CHEMISTRY; CLINICAL TRIAL; COMPARATIVE STUDY; COMPUTER ASSISTED DIAGNOSIS; FEMALE; HUMAN; MALE; METABOLISM; METASTASIS; PAIN; PALLIATIVE THERAPY; PATHOLOGY; PROSTATE TUMOR; SCINTISCANNING; SOFT TISSUE TUMOR; BONE METASTASIS; BONE SCINTISCANNING; CANCER PALLIATIVE THERAPY; CLINICAL ARTICLE; DIAGNOSTIC VALUE; DRUG UPTAKE; INTRAVENOUS DRUG ADMINISTRATION; SOFT TISSUE; WHOLE BODY SCINTISCANNING;

BONE NEOPLASMS; BREAST NEOPLASMS; DIPHOSPHONATES; FEMALE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MALE; ORGANOTECHNETIUM COMPOUNDS; PAIN; PALLIATIVE CARE; PROSTATIC NEOPLASMS; RADIOPHARMACEUTICALS; SOFT TISSUE NEOPLASMS; TECHNETIUM TC 99M DIMERCAPTOSUCCINIC ACID;

EID: 0030613907     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/00006231-199710000-00003     Document Type: Article

References (33)

1. Ohta H, Yamamoto K, Endo K el at. A new imaging agent for medullary carcinoma of the thyroid. J Nucl Med 1984; 25: 323-325.
2. Clarke SEM, Lazarus CR, Mistry R, Maisey MN. The role of tech net ium-99m pentavalent DMSA in the management of patients with medullary of the thyroid. Br J Radiol 1987; 60: 1089-1092.
3. 99Tcm-(V)-dimercaptosuccinic acid (DMSA) for imaging medullary carcinoma of the thyroid and its metastasis. Eur J Nucl Med 1988; 13: 507-510.
4. mI]MIBG, and [Wmicj MDP: An evaluation of three imaging techniques in patients with medullary carcinoma of the thyroid. J Nucl Med 1988; 29: 33-38.
5. Ohta H, Endo K, Kanoh T, Konishi J, Kotoura H. Techne-tium-99m (V) DMSA uptake in amyloidosis. J Nucl Med 1989; 30: 2049-2052.
6. Kobayashi H, Sakahara H, Itoh T et al. Technetium-99m(V)dimercaptosuccinic acid uptake in intra-abdominal massive deposit of amyloid protein. J Nucl Med 1993; 34: 815-817.
7. Ohta H, lshii M, Yoshizumi M et al. Is ECT imaging with Tc(V)-99m dimercaptosuccinic acid useful to detect lung metastases of osteosarcoma? Clin Nucl Med 1985; 10: 13-15.
8. Trapali X, Zissimopoulos A, Baziotis N et al. The application of Tc99m-V-DMSA in osteosarcoma localization (abstract). J Nucl Med 1992; 33: 708.
9. Ohta H, Endo K, Fujita T et al. Clinical evaluation of tumour imaging using 99Tc(V)m dimercaptosuccinic acid, a new tumour-seeking agent. Nucl Med Connnun 1988; 9: 105-116.
10. 99mTc(V)DMSA scintigraphy in a case of maxillary sius liposarcoma. Ann Nucl Med 1993; 7: 61-64.
11. Kobayashi H, Sakahara H, Hosono M et al. Scintigraphic evaluation of tenosynovial giant cell tumour using techne-tium-99m(V)-dimercaptosuccinic acid. J Nucl Med 1993; 34: 1745-1747.
12. Kobayashi H, Sakahara H, Hosono M et al. Soft-tissue tumours: Diagnosis with Tc-99m (V) dimercaptosuccinic acid scintigraphy. Radiology 1994; 190: 277-280.
13. Ohta H, Endo K, Fujita T et al. Imaging of head and neck tumours with technetium(V)-99m DMSA: A new tumour-seeking agent. Clin Nucl Med 1985; 10: 855-860.
14. Adams BK, Fataar A, Byrne MJ, Levitt NS, Matley PJ. Pen-tavalent technetium-99m (V)-DMSA uptake in a phaeo-chromocytoma in a patient with Sipple’s syndrome. J Nucl Med 1990; 31: 106-108.
15. Hirano T, Otake H, Yoshida I, Endo K. Primary lung cancer SPECT imaging with pentavalent technetium-99m-DMSA. J Nucl Med 1995; 36: 202-207.
16. Kao C-H, Wang S-J, Wey S-P, Shen L-H, Ting G, Yeh S-H. Using technetium-99m (V) dimercaptosuccinic acid to detect malignancies from single solid masses in the lungs. Eur J Nucl Med 1992; 19: 890-893.
17. Banzo J, Prats E, Abos MD et al. Tc-99m(V)-DMSA imaging in patients with bone lesions (abstract). Eur f Nucl Med 1993; 20: 902.
18. 99Re]rhenium(V) dimercaptosuccinic acid: A possible tumour radiotherapy agent. Appl Radiat hot 1991; 42: 167-171.
19. 2dmsa = nieso-2,3-demercaptosuccinic acid). J Chon Soc, Client Coimuun 1991; 1115-1117.
20. 188Re]-pentavalent rhenium dimercaptosuccinic acid complex. Nucl Med Commun 1993; 14: 197-203.
21. Blower PJ, Singh J, Clarke SEM, Bisunadan MM, Went MJ. Pentavalent rhenium-186 DMSA: A possible tumour therapy agent (abstract). J Nucl Med 1990; 31: 768.
22. 99mTc-dimercaptosuccinic acid. Eur j Nucl Med 1996; 23: 1575-1582.
23. 99mTc(V)DMSA. Nucl Med Commun 1987; 8: 184-185
24. Blower PJ, Singh J, Clarke SEM. The chemical identity of pentavalent technetium DMSA. J Nucl Med 1991; 32: 845-849.
25. Fogelman I, ed. Bone scanning in clinical practice. Berlin: Springer-Verlag, 1986.
26. Hirano T, Otake H, Shibasaki T, Tamura M, Endo K. Differentiating histologic malignancy of primary brain tumors: Pentavalent technetium-99m-DMSA. J Nucl Med 1997; 38: 20-26.
27. Siegel ME, Walker WJ Jr, Campbell JL II. Accumulation of Tc-99m-diphosphonate in malignant pleural effusions: Detection and verification. J Nucl Med 1975; 16: 883-885.
28. Lamki L, Cohen P, Driedger A. Malignant pleural effusion and Tc-99m-MDP accumulation. Clin Nucl Med 1982; 7: 331-333.
29. Goldstein HA, Gefter WB. Detection of unsuspected malignant pleural effusion by bone scan. Clin Nucl Med 1984; 9: 556-557.
30. 99mTc-methylene diphosphonate in malignant pleural and ascitic effusions. Oncology 1984; 41: 427-430.
31. Shih WJ, Coupal JJ. Diffuse thoracoabdominal radioactivity seen in bone imaging. Clin Nucl Med 1986; 11: 254-258.
32. Babbel RW, Jackson DE, Conte FE. Technetium-99m-MDP accumulation in a non-malignant pleural effusion. Clin Nucl Med 1988; 13: 298-299.
33. Callahan AP, Rice DE, Knapp FF Jr. Rhenium-188 for therapeutic applications from an alumina based tungsten-188/rhenium-188 radionuclide generator. NUC Compact 1989;20:3-6.